Sector Experience

Healthcare
Technology
Life Sciences & Pharma

Languages

English
Spanish
32
years

Years of Experience

1/20

Member Since


Fortune 500
Top Consulting Firms

Experience

 
Lontra Ventures, LLC Management Consulting
President
04/2008 - Present
Lontra Ventures is a management consulting firm with particular expertise in specialty therapeutics such as oncology, rheumatology, dermatology, osteoporosis, and migraine. Over the past several years, we have worked with large and small pharmaceutical manufacturers, medical device firms, diagnostics companies, and healthcare service businesses to help them grow. We have led market diligence, lifecycle management, and product launch projects for some of the world's largest drug and device firms.

McKesson Corporate Strategy & Development
Vice President, Business Development
10/2007 - 04/2008
Led post-merger integration of all manufacturer-facing activities for McKesson Specialty and OTN/Onmark: people, processes, technology and strategy. Completed all deliverables on time and within budget.

Oncology Therapeutics Network Corporate Strategy & Development
Vice President, Business Development
08/2005 - 10/2007
Took division of Bristol-Myers Squibb private. Negotiated and managed more than $1.5B in annual buy/sell agreements with pharmaceutical manufacturers. Grew high-margin, value added services revenue stream from zero to $40M in three years. Managed a team of high achieving sales and service personnel who delivered complex marketing/promotion and information services to sales, marketing, and market research teams at global pharmaceutical companies.

Bristol-Myers Squibb Corporate Strategy & Development
Vice President, Business Development
04/2003 - 08/2005
Chaired Commercial Strategy and Operations Team responsible for increasing OTN division's revenue, gross profit and market share. Developed strategy and implementation plan for OTN’s entry into the specialty pharmacy market. Interviewed more than 20 health plan executives, developed business models, company positioning, and customer value propositions. Result: OTN acquired ivpcare, the nation’s largest, privately held specialty pharmacy.

Vignette Marketing
Director, Product Marketing
10/2000 - 11/2002
Led Product Marketing for Vignette's 2 packaged, J2EE applications. Positioned and launched portal application, which became the fastest growing new product in Vignette history with more than 40 customers ($8M revenue) in first 6 months. Developed pricing; wrote product collateral; trained and educated sales and channel partners in the US, Europe, and Asia; briefed industry analysts and the press. Developed financial model to measure P&L impact of Vignette's largest channel & tech partners.

Becton Dickinson Marketing
Director of Marketing & Business Development
02/1998 - 07/2000
Member of executive management team that formulated strategy and oversaw P&L performance of start-up healthcare software division with budget of $12M and sales of $4.6M. Acquired/integrated a company with 600 customers, 25 employees and 50 SKUs. Grew division from 4 to 70 employees in 2 years.

Booz Allen Hamilton Management Consulting
Associate
07/1995 - 09/1997
Developed business and marketing strategies for $6B firm's cardiovascular business and $1B firm's oncology business. Analyzed financial and strategic fit of $500M acquisition candidate. Evaluated R&D projects and new product/market opportunities for a $1B company to fill $150M revenue gap.

Accenture Management Consulting
Senior Consultant
07/1989 - 07/1993
Supervised a project team of 8 and managed a budget of $250K to design and create Astra/Merck's Licensing and Business Development function. Drove and facilitated meetings of marketing and R&D executives to create initial vision and strategy that enabled Astra/Merck to build sustainable competitive advantage in the GI, cardiovascular, and CNS therapeutic areas. AstraZeneca acquired Merck's 50% stake in 1995 for $800M.